U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088718) titled 'Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data' on July 19.
Brief Summary: Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Study Start Date: Oct. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes
Major Adverse Cardiac Events
Cardiovascular (CV) Risk
Intervention:
DRUG: Tirzepatide
New use of tirzepatide dispensing claim ...